Rajasthan HC Orders Cyber Safety Reforms, Covering Influencer Rules and Aadhaar-Linked Digital IDs  ||  Bombay HC: SEBI Exercised Due Care and Caution in Approving the Wework India IPO Proposal  ||  Delhi HC: FEMA Summons Follow CPC, Not CrPC; ED May Call Women to Office For Statement Recording  ||  Kerala HC: Further Probe under Section 173(8) CrPC Allowed Only by Original Investigating Agency  ||  Delhi HC: Parties Must First Ask Social Media Platforms to Remove Content Before Seeking Injunction  ||  Supreme Court: Prosecutor Cannot Neglect Duty to Court in Pursuit of Securing Conviction  ||  Supreme Court: Selection Criteria Cannot be Altered After Interviews are Conducted  ||  NCLT Mumbai: Pending Cheque-Bounce Case Does not Prevent Admission of Insolvency Petition  ||  Kerala HC: Applications under the Muslim Women’s Divorce Act Have a 3-Year Limitation Period  ||  Supreme Court: Property Transferred Before Filing a Suit Cannot be Attached under Order 38 Rule 5    

Delhi HC Issue Directions to Ensure Immediate Availability of Tocilizumab for Critically Ill Patients - (06 May 2021)

CIVIL

Delhi High Court has directed the Centre to inform the Court about the stock available for distribution of the Covid drug Tocilizumab to various Hospitals and Medical Establishments in Delhi. The Court has also directed the Centre to place on record details of entities to whom approvals have been granted of Tocilizumab for manufacturing, marketing, importing or selling in India.

Tags : DELHI HIGH COURT   AVAILABILITY OF TOCILIZUMAB  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved